Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
暂无分享,去创建一个
A L Baert | G Marchal | H Bosmans | W Semmler | Y. Ni | Y. Miao | G. Marchal | H. Bosmans | W. Semmler | A. Baert | J. Yu | J Yu | Y Ni | C Petré | Y Miao | E Cresens | P Adriaens | C. Petré | E. Cresens | P. Adriaens
[1] P D Schneider,et al. Liver resection and laser hyperthermia. , 1992, The Surgical clinics of North America.
[2] R. Lauffer,et al. Targeted relaxation enhancement agents for MRI , 1991, Magnetic resonance in medicine.
[3] D Revel,et al. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice. , 1987, Investigative radiology.
[4] J. Sessler,et al. Preclinical Evaluation of Gadolinium (III) Texaphyrin Complex: A New Paramagnetic Contrast Agent for Magnetic Resonance Imaging , 1994, Investigative radiology.
[5] R. Fiel,et al. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors. , 1990, Magnetic resonance imaging.
[6] S. H. Koenig,et al. Tissue distribution and stability of metalloporphyrin MRI contrast agents , 1987, Magnetic resonance in medicine.
[7] D I Rosenthal,et al. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. , 1996, Academic radiology.
[8] C. Compton,et al. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. , 1996, Academic radiology.
[9] U Schmiedl,et al. Porphyrins as contrast media , 1991, Magnetic resonance in medicine.
[10] U Schmiedl,et al. Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers. , 1990, Investigative radiology.
[11] A. Sharma,et al. MnPcS4: a new MRI contrast enhancing agent for tumor localisation in mice. , 1995, Magnetic resonance imaging.
[12] J. Winkelman,et al. The concentration in tumor and other tissues of parenterally administered tritium- and 14-C-labeled tetraphenylporphinesulfonate. , 1967, Cancer research.
[13] J. S. Cohen,et al. Paramagnetic metalloporphyrins as potential contrast agents in NMR imaging , 1984, FEBS letters.
[14] K. Hossmann,et al. Proton relaxation enhancement in experimental brain tumors--in vivo NMR study of manganese(III)TPPS in rat brain gliomas. , 1990, Magnetic resonance imaging.
[15] H. Pass,et al. Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.
[16] P. Furmanski,et al. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. , 1988, Cancer research.
[17] S. Bown,et al. Role of interstitial therapy in the treatment of liver cancer , 1991, The British journal of surgery.
[18] Thierry Patrice,et al. Tetra‐p‐aminophenylporphyrin conjugated with Gd‐DTPA: Tumor‐specific contrast agent for MR imaging , 1993, Journal of magnetic resonance imaging : JMRI.
[19] C J Gomer,et al. Photodynamic therapy in the treatment of malignancies. , 1989, Seminars in hematology.
[20] P. V. van Zijl,et al. MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T. , 1992, Magnetic resonance imaging.
[21] A L Baert,et al. Localization of metalloporphyrin-induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. , 1995, Academic radiology.
[22] G. Glover,et al. Experimental Hepatic Tumor Necrosis: Comparison of Spin-Echo and Pulsed Magnetization Transfer Contrast Magnetic Resonance Imaging , 1993, Investigative radiology.
[23] D. Kessel,et al. Porphyrin localization: a new modality for detection and therapy of tumors. , 1984, Biochemical pharmacology.